Wu Qiong, Zhao Tiantian, Zhu Chenglou, Da Mingxu
The First School of Clinical Medicine, Lanzhou University, Lanzhou, 730000, China.
The First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, 730000, China.
Obes Surg. 2024 Apr;34(4):1061-1072. doi: 10.1007/s11695-024-07059-x. Epub 2024 Jan 17.
We conducted a meta-analysis of current literature to assess whether bariatric surgery(BS) has a positive effect on reducing the risk of multiple myeloma(MM).
Relevant studies meeting the criteria were systematically reviewed using databases such as PubMed, Web of Science, Embase (Ovid platform), MEDLINE, and the Cochrane Library. The meta-analysis utilized hazard ratios (RR) and 95% confidence intervals (CI) to analyze the correlation between BS and the risk of MM. STATA software (version 12.0) was employed for the meta analysis.
The meta-analysis included 10 eligible studies, involving 2,452,503 patients with obesity. The results demonstrated a significant reduction in the risk of multiple myeloma in patients with obesity after bariatric surgery compared to non-surgical patients with obesity (RR = 0.51, 95%CI: 0.31-0.84). Subgroup analyses revealed a decreased probability of developing multiple myeloma in European patients with obesity and North American patients with obesity who underwent bariatric surgery. Studies with a sample size greater than or equal to 100,000 indicated a significantly reduced risk of multiple myeloma in patients with obesity undergoing bariatric surgery compared to the non-surgical group (RR: 0.45, 95%CI: 0.23-0.88, P < 0.02). Two publications before 2010 showed no significant difference in the incidence of multiple myeloma between the surgical and non-surgical groups (RR: 0.61, 95% CI: 0.14-2.63, P = 0.504), while publications after 2010 demonstrated a reduced incidence in the surgical group (RR: 0.51, 95% CI: 0.30-0.86, P = 0.012).
Our meta-analysis results suggest a reduced risk of multiple myeloma in patients with obesity following bariatric surgery.
CRD42023485668.
我们对当前文献进行了一项荟萃分析,以评估减肥手术(BS)是否对降低多发性骨髓瘤(MM)风险具有积极作用。
使用PubMed、Web of Science、Embase(Ovid平台)、MEDLINE和Cochrane图书馆等数据库,对符合标准的相关研究进行系统综述。荟萃分析采用风险比(RR)和95%置信区间(CI)来分析减肥手术与多发性骨髓瘤风险之间的相关性。使用STATA软件(版本12.0)进行荟萃分析。
荟萃分析纳入了10项符合条件的研究,涉及2452503例肥胖患者。结果表明,与未接受手术的肥胖患者相比,接受减肥手术的肥胖患者患多发性骨髓瘤的风险显著降低(RR = 0.51,95%CI:0.31 - 0.84)。亚组分析显示,接受减肥手术的欧洲肥胖患者和北美肥胖患者患多发性骨髓瘤的概率降低。样本量大于或等于100000的研究表明,与非手术组相比,接受减肥手术的肥胖患者患多发性骨髓瘤的风险显著降低(RR:0.45,95%CI:0.23 - 0.88,P < 0.02)。2010年前的两篇出版物显示,手术组和非手术组多发性骨髓瘤的发病率无显著差异(RR:0.61,95%CI:0.14 - 2.63,P = 0.504),而2010年后的出版物显示手术组发病率降低(RR:0.51,95%CI:0.30 - 0.86,P = 0.012)。
我们的荟萃分析结果表明,减肥手术后肥胖患者患多发性骨髓瘤的风险降低。
PROSPERO注册编号:CRD42023485668。